Defining the role of frailty in the transition from mild cognitive impairment to dementia and in dementia progression
Alberto Benussi,Irene Mattioli,Chiara Silvestri,Ilenia Libri,Silvio Zampini,Maura Cosseddu,Rosanna Turrone,Claudia Amolini,Salvatore Caratozzolo,Barbara Borroni,Alessandra Marengoni,Alessandro Padovani
DOI: https://doi.org/10.1159/000535789
2024-02-28
Dementia and Geriatric Cognitive Disorders
Abstract:Introduction: Neurodegenerative diseases are a growing concern in an aging global population. Frailty, often conceptualized as a state of diminished physiological reserve and increased susceptibility to stressors, emerges as a pivotal factor in this context. While frailty may be modified, it is essential to recognize its frequently irreversible nature, necessitating a careful approach when considering its role and influence in the progression from Mild Cognitive Impairment (MCI) to dementia and within dementia progression. Methods: A retrospective study including 1284 participants from January 2021 to May 2023, was conducted. Frailty was assessed using the clinical frailty scale (CFS) score. Multilevel univariate and multivariate logistic regression models were developed to determine the contributions of patient characteristics, including frailty, to disease progression. Results: Frailty significantly increased with higher global clinical dementia rating (CDR) subgroups, suggesting escalating frailty burden with disease progression. Age, CFS, and mini-mental state examination (MMSE) scores were significant predictors of progression from MCI to dementia and to more severe dementia stages, even when considering the independence from variables contributing to frailty. Patients transitioning to a higher CDR group exhibited higher CFS scores. Age, education, anticholinergic burden, cumulative illness rating scale-geriatric, MMSE, and neuropsychiatric inventory scores significantly contributed to frailty. Conclusions: Frailty plays a critical role in the transition from MCI to dementia and within dementia progression. Age, cognitive impairment, and frailty were identified as significant predictors of disease progression. The CFS is a clinically applicable tool for frailty assessment. Regular frailty assessments may be valuable in early detection and management of dementia.
psychiatry,clinical neurology,geriatrics & gerontology,gerontology